The resale registration creates near-term overhang as Armistice Capital can sell up to 404,166 shares. With the stock trading at $11.03, below the $12.00 warrant exercise price, cash exercise is unlikely unless the stock appreciates. Monitor for selling activity and any future dilution from the remaining 389,846 outstanding warrants.
Executive Summary
Polyrizon Ltd. filed a new F-1 registration statement to register 404,166 ordinary shares for resale by Armistice Capital Master Fund Ltd., the sole selling shareholder. The shares are issuable upon exercise of warrants from a September 2026 private placement that raised approximately $4.0 million in gross proceeds. The company will not receive any proceeds from the resale but may receive up to $4.0 million if the warrants are exercised for cash.
Key Facts
- F-1 registers 404,166 ordinary shares for resale by Armistice Capital Master Fund Ltd., representing ~16.8% of current outstanding shares (2,402,067).
- Shares consist of 70,833 from pre-funded warrants and 333,333 from ordinary share warrants, both issued in the September 2026 private placement.
- September 2026 offerings raised ~$4.0 million gross proceeds via 232,500 shares at $12.00 and 30,000 pre-funded warrants at $11.99999.
- Warrant exercise price is $12.00 per share for ordinary share warrants; pre-funded warrants have a nominal exercise price of $0.00001.
- Last reported sale price on September 17, 2026, was $11.03 per share, below the $12.00 warrant exercise price.
- Armistice Capital beneficially owns 943,381 shares pre-offering (including prior April 2026 warrants and direct holdings) and would retain 539,215 shares (19.20%) after selling the maximum.
- Company is pre-revenue with net losses of $3.3 million in 2025 and $1.5 million in 2024.
- Cash and cash equivalents were $1.3 million as of December 31, 2025, with pro forma cash of $7.9 million after recent financings.
Financial Impact
Potential dilution of ~16.8% from the 404,166 shares registered for resale; potential cash proceeds to the company of up to ~$4.0 million if warrants are exercised for cash.
Risk Factors
- Significant dilution risk from the 404,166 shares registered for resale, representing ~16.8% of current outstanding shares.
- Potential further dilution from 389,846 additional warrants outstanding with a weighted average exercise price of $25.12.
- Pre-revenue development-stage company with no approved products and increasing operating losses.
- Stock trading below warrant exercise price ($11.03 vs $12.00) may limit cash exercise and signal weak demand.
- Israeli company with exposure to geopolitical risks and potential difficulties enforcing U.S. securities laws.
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| F-1 Filing (Primary) | 0001213900-26-101441 |
| Document: ea030580701ex-fee.htm | 0001213900-26-101441 |
| Document: ea030580701ex5-1.htm | 0001213900-26-101441 |
| Document: ea030580701ex23-1.htm | 0001213900-26-101441 |
| Document: 0001213900-26-101441-index-headers.html | 0001213900-26-101441 |
| Document: 0001213900-26-101441-index.html | 0001213900-26-101441 |
| Document: 0001213900-26-101441.txt | 0001213900-26-101441 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 5, 2026 21d ago | 6-K | $9.67 $9.15 | ▼ −5.37% | ▼ −5.13% | $8.96 (−7.37%) |
Oct 2, 2026 24d ago | EFFECT | $9.61 $9.26 | ▲ +3.64% | ▲ +4.32% | $8.96 (+6.79%) |
Sep 22, 2026 4w ago | Press Release | $10.66 $11.16 | ▲ +4.69% | ▲ +5.41% | $8.96 (−15.97%) |
Sep 18, 2026 5w ago | F-1 | $10.90 $10.66 | ▲ +2.20% | ▲ +2.19% | $8.96 (+17.82%) |
Sep 4, 2026 7w ago | Press Release | $11.24 $11.15 | ▲ +0.80% | ▲ +0.25% | $8.96 (+20.31%) |
Sep 4, 2026 7w ago | 6-K | $11.24 $11.15 | ▲ +0.80% | ▲ +0.25% | $8.96 (+20.31%) |
Sep 4, 2026 7w ago | 424B5 | $11.24 $11.15 | ▲ +0.80% | ▲ +0.25% | $8.96 (+20.31%) |
Aug 20, 2026 9w ago | 6-K | $10.30 $10.70 | ▲ +3.88% | ▲ +4.18% | $8.96 (−13.04%) |
Jul 13, 2026 15w ago | 6-K | $13.76 $13.07 | ▼ −4.98% | ▼ −5.38% | $8.96 (−34.88%) |
Jul 2, 2026 16w ago | 6-K | $13.80 $15.21 | ▲ +10.20% | ▲ +9.32% | $8.96 (−35.09%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers